DESNT: A Poor Prognosis Category of Human Prostate Cancer.

about

DESNT: A Poor Prognosis Category of Human Prostate Cancer.

Item

http://www.wikidata.org/entity/Q38655020

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

DESNT: A Poor Prognosis Category of Human Prostate Cancer.

@en

type

Item

label

DESNT: A Poor Prognosis Category of Human Prostate Cancer.

@en

prefLabel

DESNT: A Poor Prognosis Category of Human Prostate Cancer.

@en

P1476

DESNT: A Poor Prognosis Category of Human Prostate Cancer

@en

P2093

Alastair D Lamb

http://www.w3.org/2001/XMLSchema#string

Anne Y Warren

http://www.w3.org/2001/XMLSchema#string

Bogdan-Alexandru Luca

http://www.w3.org/2001/XMLSchema#string

CancerMap Group

http://www.w3.org/2001/XMLSchema#string

Colin S Cooper

http://www.w3.org/2001/XMLSchema#string

David E Neal

http://www.w3.org/2001/XMLSchema#string

Dylan R Edwards

http://www.w3.org/2001/XMLSchema#string

Hayley C Whitaker

http://www.w3.org/2001/XMLSchema#string

Helen Curley

http://www.w3.org/2001/XMLSchema#string

Helen Ross-Adams

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression profiling predicts clinical outcome of prostate cancer

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Repeated observation of breast tumor subtypes in independent gene expression data sets

Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy

A molecular signature of metastasis in primary solid tumors

Regularization Paths for Generalized Linear Models via Coordinate Descent

Adjusting batch effects in microarray expression data using empirical Bayes methods

limma powers differential expression analyses for RNA-sequencing and microarray studies

Integrative genomic profiling of human prostate cancer

Identification of prognostic signatures in breast cancer microarray data using Bayesian techniques.

P304

842-850

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EUF.2017.01.016

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andy G. Lynch

Rosalind Eeles

Daniel Brewer

P577

2017-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28753852

http://www.w3.org/2001/XMLSchema#string

P932

5669460

http://www.w3.org/2001/XMLSchema#string